Navigation Links
Eliminating rare diseases
Date:1/24/2013

al Rare Diseases Research Consortium (IRDiRC), under which these new grants have been awarded, aims to accelerate research into rare diseases. Professor Paul Lasko of McGill University in Montral, Canada, Chair-Elect of the IRDiRC Executive Committee, explained: "IRDiRC's goal is to reach 200 new rare disease therapies, and diagnoses for all rare diseases, by the year 2020. To this end, it is today launching three major projects which will combine international genetic data with clinical information and data on biomaterials to help interpret the vast amounts of data the genome yields. This will aid scientists in the search for genetic causes of diseases and help identify new ways to create targeted therapies".

Professor Lochmller said: "Already we have drugs being tested in clinical trials which can, in effect, patch up the faults in the genes for some rare diseases such as Duchenne muscular dystrophy. Drugs like this are at the vanguard of a new generation of therapies that change a person's genes rather than just treating their symptoms, and they have the potential to make a real difference to the quality of life of people with the condition. By sharing data and clinical expertise in this structured way across an international network, we hope to discover similar life-changing drugs for other rare diseases."

A rare disease is defined by the European Union as one that affects fewer than five people in every 10,000 of the general population. There are between 6,000 and 8,000 known rare diseases, and approximately 30 million people across Europe are affected by a rare disease.

The four IRDiRC projects being launched in Barcelona today have received nearly 40 million EUR of funding for cutting-edge research and collaboration over the next six years. Funding focuses on international collaborations:

  • Identifying the genetic and epigenetic causes of rare kidney disorders EURenOmics led by Heidelberg University Medical Centre, Germa
    '/>"/>

Contact: Karen Bidewell
press.office@ncl.ac.uk
44-019-122-27850
Newcastle University
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Eliminating useless information important to learning, making new memories
2. An error-eliminating fix overcomes big problem in 3rd-gen genome sequencing
3. Immune cell death defects linked to autoimmune diseases
4. Stem cell materials could boost research into key diseases
5. The findings between DNMs and autism provides global view of mutability on human diseases
6. Transplanted genetically-modified adipose cells offer potential therapy for liver diseases
7. Removing protein garbage in nerve cells may help control 2 neurodegenerative diseases
8. Short DNA strands in the genome may be key to understanding human cognition and diseases
9. Scientists question the designation of some emerging diseases
10. Call for global monitoring of infectious diseases in dogs and cats
11. Action needed to prevent more devastating tree diseases entering the UK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... interaction of a group of proteins in the brain ... a new target that could increase cell survival. , ... of Biochemistry and published in the EMBO journal ... lead to new therapies for stroke and other brain ... the team which identified a protein, known as SUMO, ...
(Date:5/17/2013)... climate change may have little impact on many ... recent studies that predict their widespread extinction in ... appear in the journal Global Change Biology ... creature thought to be doomed: http://onlinelibrary.wiley.com/doi/10.1111/gcb.12253/abstract ... forest lizards, will be hard hit by climate ...
(Date:5/16/2013)... 2013) Illustrating a commitment to the support ... Association (AGA) Research Foundation has announced the inaugural ... Award recipients. Supported by the National Institute of ... new award helps underrepresented minority students to further ... research. , "By establishing this new award, AGA ...
Breaking Biology News(10 mins):SUMO wrestling cells reveal new protective mechanism target for stroke 2Climate change may have little impact on tropical lizards 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... the Antwerp Institute of Tropical Medicine (ITG) have developed ... biting midges that spread bluetongue disease. Until know this ... how the disease spreads, and how to control it. ... Entomology . Bluetongue primarily affects sheep, but also ...
... that can lead to life-threatening heart and digestive disorders, ... according to research from The University of Texas at ... now, and this year the number of disease-causing insects ... biology and philosophy at The University of Texas at ...
... National Institutes of Health (NIH) has awarded a Rutgers-affiliated ... of tissue from breast cancer biopsies. The technology is ... breast cancer is likely to be, helping physicians and ... The NIH made its grant to Ibris, Inc., through ...
Cached Biology News:Vectors of bluetongue get a name 2Chagas disease may be a threat in South Texas, says researcher 2Rutgers-affiliated company receives funding for technology to help choose breast cancer treatments 2Rutgers-affiliated company receives funding for technology to help choose breast cancer treatments 3
(Date:5/17/2013)... 2013 - Elsevier, a world-leading provider of scientific, technical ... publication of a recent study in Reproductive ... showing that those with an abnormal chromosomal composition can ... developed to blastocysts, thereby classifying the risk of genetic ... same group has undertaken a retrospective study, using their ...
(Date:5/17/2013)... USA (PRWEB) May 17, 2013 •    First ... Globes Certified for sustainability ,     New facility will ... , Syngenta unveiled its new ... at the company’s RTP Innovation Center. The first of ... researchers to simulate any agricultural climate and precisely measure ...
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
(Date:5/17/2013)... SAN JOSE, Calif. , May 17, 2013 ... an agreement has been reached with ... entire portfolio of anti-infective human monoclonal antibody (mAb) ... six anti-infective human mAb products for treatment of ... strains of Staphylococcus aureus , Pseudomonas ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... Lucid, Inc., (http://www.lucid-tech.com ) today announced the ... network. The network is designed to transfer ... Lucid,s,non-invasive VivaScope(R) Confocal Imagers with pathologists or ... microscopes provide non-invasive,in- vivo cellular resolution images ...
... ... Product,s Lifecycle, NEW YORK, Feb. 12 ... leader in patient,enrollment for clinical trials, will join the Ketchum network, ... Ketchum,will greatly expand the depth of services offered to its healthcare,clients. ...
... 12 More than 400 generic,industry leaders, financial ... Pharmaceutical Association (GPhA) Annual Meeting to discuss,the critical ... the theme of,"Generics: The Right Choice for Better ... in this important,legislative and election year., "Voters ...
Cached Biology Technology:Lucid Launches VivaNet(R) Telemedicine Server for Dermatology Applications 2Lucid Launches VivaNet(R) Telemedicine Server for Dermatology Applications 3Ketchum Joins Forces with Clinical Trial Recruitment Agency MMG 2Ketchum Joins Forces with Clinical Trial Recruitment Agency MMG 3Ketchum Joins Forces with Clinical Trial Recruitment Agency MMG 4GPhA Annual Meeting Focuses on Industry Opportunities and Challenges for 2008 2
... 100 Amplification Kit, 100 reactions. Prepare ... in 4-6 h.Generate microgram quantities of ... starting material.Use amplified DNA directly for ... bacterial or M13 liquid cultures, colonies, ...
Polypropylene test tube racks, used in Thermo Forma's line of Test Tube Rack holders...
For quantitative determination of Aldolase in Serum (an indicator of muscle damage). Ready-to-use liquid stable reagent. Formulated to eliminate interference from pyruvates. Application sheets are ...
This Universal 24" X 18" (61 X 45.7cm.) shaker platforms will accept any Thermo Forma shaker flask clip....
Biology Products: